EUVIMEDEUVIMED entdecken
Crossref

Preoperative use of serotonergic antidepressants is associated with increased rates of complications and surgical revision in autologous breast reconstruction

Matthew Q Dao, Jacquelyn M Roth, Bernice Z Yu, Keisha E Montalmant, Parul Rai, Arjun Nanda, Jasmin Wilson, Peter W Henderson

Journal of Plastic, Reconstructive & Aesthetic Surgery · 2025

DOI: 10.1016/j.bjps.2025.08.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2025. Verfasst von Matthew Q Dao und 7 weiteren Autor:innen. Beteiligte Einrichtung: John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States of America; Division of Plastic and Reconstruct…. Hauptthemen laut MEDLINE: Mammaplasty, Postoperative Complications, Selective Serotonin Reuptake Inhibitors, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Depression and anxiety are common among women with breast cancer scheduled for autologous breast reconstruction, with selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors serving as the first-line treatments. Although effective for mood disorders, perioperative use of these medications has been linked to impaired hemostasis and wound healing in recovering patients. We evaluated the association between preoperative serotonergic antidepressants and complications following reconstructive breast surgery. METHODS: Female patients were identified from the US collaborative network within TriNetX, a globally federated database. Adults (18 years and older) who underwent autologous breast reconstruction were stratified into 2 groups: those prescribed serotonergic antidepressants within 3 months preoperatively (n = 4434), and those without any documented use (n = 13,661). Propensity score matching controlled for demographics and comorbidities. Primary outcomes were postoperative complications within 90 days. Secondary outcomes included deformity of reconstructed breast and surgical revision at 1 and 2 years. Risk ratios (RR) were used to measure associations, with statistical significance set at p < 0.05. RESULTS: After matching, 3064 patients remained in each group. Patients who used serotonergic antidepressants before autologous breast reconstruction had significantly higher risks of developing complications, including sepsis (RR = 1.94, p = 0.004), seroma (RR = 1.58, p = 0.004), hematoma (RR = 1.29, p = 0.037), and surgical site infection (RR = 1.54, p < 0.0001), within 90 days. At 1 and 2 years, the rates of breast deformity and revision were also significantly elevated (p < 0.01). CONCLUSION: Preoperative serotonergic antidepressant use is associated with increased short- and long-term complications following autologous breast surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MammaplastyPostoperative ComplicationsSelective Serotonin Reuptake InhibitorsBreast NeoplasmsAntidepressive AgentsDepressionHumansFemaleMiddle AgedAdultReoperationRetrospective StudiesPreoperative CareSerotonin and Noradrenaline Reuptake Inhibitors

Stichwörter der Autor:innen

AnxietyAutologous breast reconstructionDepressionSerotonergic antidepressants

Substanzen

Selective Serotonin Reuptake InhibitorsAntidepressive AgentsSerotonin and Noradrenaline Reuptake Inhibitors

Autor:innen und Institutionen

  • John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States of America; Division of Plastic and Reconstructive Surgery, Department of Surgery, Icahn School of Medicine at Mount…
  • Division of Plastic and Reconstructive Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10003, United States of America.
  • John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States of America.

Zitieren

APA

Dao, M. Q., Roth, J. M., Yu, B. Z., Montalmant, K. E., Rai, P., Nanda, A., Wilson, J., & Henderson, P. W. (2025). Preoperative use of serotonergic antidepressants is associated with increased rates of complications and surgical revision in autologous breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2025.08.025

Vancouver

Dao MQ, Roth JM, Yu BZ, Montalmant KE, Rai P, Nanda A, et al. Preoperative use of serotonergic antidepressants is associated with increased rates of complications and surgical revision in autologous breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2025. doi:10.1016/j.bjps.2025.08.025

BibTeX
@article{Dao2025,
  author = {Dao, Matthew Q and Roth, Jacquelyn M and Yu, Bernice Z and Montalmant, Keisha E and Rai, Parul and Nanda, Arjun and Wilson, Jasmin and Henderson, Peter W},
  title = {Preoperative use of serotonergic antidepressants is associated with increased rates of complications and surgical revision in autologous breast reconstruction},
  journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
  year = {2025},
  doi = {10.1016/j.bjps.2025.08.025}
}
Kostenlos starten →